Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Trends & Analysis - Forecasts to 2026 By Derived Cell Type (Fibroblasts, Amniotic Cells, Hepatocytes, Keratinocytes, Others), By End Users (Research Organizations, Hospitals), By Application (Drug Development, Regenerative Medicine, Academic Research, Toxicity Testing), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis

Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Trends & Analysis - Forecasts to 2026 By Derived Cell Type (Fibroblasts, Amniotic Cells, Hepatocytes, Keratinocytes, Others), By End Users (Research Organizations, Hospitals), By Application (Drug Development, Regenerative Medicine, Academic Research, Toxicity Testing), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis

  • Published Date: May 27 : 2020
  • Base Year for Estimate: 2019
  • Report Id:2035

Induced Pluripotent Stem Cells (iPSCs) Market: Insights

The global Induced Pluripotent Stem Cells (iPSCs) market is expected to generate revenue amounting to USD 1,509.43 million in 2020, and is projected to reach to USD 2,216.95 million by 2026, growing at a CAGR of 6.62% over the forecast period. Increased research funding, growth in number of genomic projects, and increasing use of genome engineering in personalized medicine are some of the major factors expected to propel the market growth during the forecast period. Induced pluripotent stem cells are used to develop cells or tissues required by the body to defend or combat many diseases such as leukemia, spinal cord injury, heart disease, and diabetes among others. iPSCs are used in different applications such as toxicology testing, high throughput, disease modeling, and target identification among others.

Growing awareness among the people about stem cells and induced pluripotent stem cells are likely to boost the market growth during the forecast period. Rise in stem cell-based research and huge success of regenerative medicine are expected to fuel market growth for induced pluripotent system cell. Increasing interest among scientists and researchers in the field of disease treatments across various regions including North America, Europe, Asia Pacific, and Central & South America is further projected to propel the market growth of Induced Pluripotent Stem Cells (iPSCs). However, increasing costs associated with the treatment and reprogramming of cells, lengthy processes, and ethical issues are likely to hamper the market growth during the forecast period.

Induced Pluripotent Stem Cells (iPSCs) Market

Induced Pluripotent Stem Cells (iPSCs) Market Segmentation

The global Induced Pluripotent Stem Cells (iPSCs) market is segmented on the basis of cell type into fibroblasts, amniotic cells, hepatocytes, and keratinocytes, among others. The amniotic cells segment is expected to grow at a significant market share during the forecast period. Amniotic stem cells are the mixture of stem cells that can be obtained from the amniotic fluid as well as the amniotic membrane. These cells are developed into various tissue types including skin, cartilage, cardiac tissue, nerves, muscle, and bone among others. The hepatocytes segment is expected to grow at a significant rate during the forecast period. Growing usage of hepatocytes in cell biological and biopharmaceutical research are driving the market growth.

On the basis of application, the global induced pluripotent stem cells (iPSCs) market is segmented into drug development, regenerative medicine, toxicity testing, and academic research. The regenerative medicine segment is expected to hold the largest market share during the forecast period. Rising adoption and ongoing development of companion diagnostics and personalized medicine for usage in oncology and other chronic infections is driving the market growth for regenerative medicine segment. The drug development segment is expected to grow at a highest CAGR during the forecast period. Drug manufacturers have adopted these cells for the identification of novel therapies, research, and toxicology testing as stem cell technology can produce cells that are in-line with the gold standard required for drug safety testing.

Induced Pluripotent Stem Cells (iPSCs) Market

Induced Pluripotent Stem Cells (iPSCs) Market: Regional Analysis

On the basis of region, the market of induced pluripotent stem cells (iPSCs) is segmented into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. The North America region is expected to dominate the global induced pluripotent stem cells (iPSCs) market during the forecast period. High R&D investments in cytological research and increasing market adoption of stem cell therapies are some of the major factors driving the market growth in the region.  Strong reimbursement framework, and advanced healthcare framework are also driving the market growth in the region. Presence of major biotechnology companies in the U.S., and extensive government funding in the country is propelling the market growth. The Asia Pacific region is expected to grow at a significant CAGR during the forecast period. Increasing number of research projects in countries such as Japan, Singapore, and Australia is anticipated to propel the market growth in the region during the forecast period.

Induced Pluripotent Stem Cells (iPSCs) Market: Use Cases

Induced pluripotent stem cells (iPSCs or iPS cells) are a form of pluripotent stem cells, generated directly from somatic (adult) cells. Pluripotent stem cells have significant potential in regenerative medicine. These possess the potential and capability to form various types of adult cells such as liver, heart, neurons, and pancreatic cells. These cells can proliferate indeterminately and can be used to repair or replace cells that are damaged due to diseases. Induced pluripotent stem cells help in understanding human development at an early stage and helps to develop rejection-proof, customized cells and tissues for efficacious transplantation.

In April 2020, Fate Therapeutics announced worldwide collaboration with Janssen for novel iPSC-derived cell-based cancer immunotherapies. Under the multi-year collaboration agreement, Janssen will contribute proprietary antigen binding domains for four tumor-associated antigen targets

In January 2020, Allele and Astellas signed an agreement to expand license for the development of iPSC lines.

Induced Pluripotent Stem Cells (iPSCs) Market: By Derived Cell Type

  1. Introduction   
    1. Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026 (USD Million)
  2. Fibroblasts    
    1. Fibroblasts : Induced Pluripotent Stem Cells (iPSCs) Market, 2020-2026 (USD Million)
  3. Amniotic Cells
    1. Amniotic Cells: Induced Pluripotent Stem Cells (iPSCs) Market, 2020-2026 (USD Million)
  4. Hepatocytes  
    1. Hepatocytes: Induced Pluripotent Stem Cells (iPSCs) Market, 2020-2026 (USD Million)
  5. Keratinocytes
    1. Keratinocytes: Induced Pluripotent Stem Cells (iPSCs) Market, 2020-2026 (USD Million)
  6. Others
    1. Others: Induced Pluripotent Stem Cells (iPSCs) Market, 2020-2026 (USD Million)

Induced Pluripotent Stem Cells (iPSCs) Market: By End Users

  1. Introduction   
    1. Induced Pluripotent Stem Cells (iPSCs) Market, By End Users Type, 2020-2026 (USD Million)
  2. Research Organizations         
    1. Research Organizations: Induced Pluripotent Stem Cells (iPSCs) Market, 2020-2026 (USD Million)   
  3. Hospitals       
    1. Hospitals: Induced Pluripotent Stem Cells (iPSCs) Market, 2020-2026 (USD Million)

Induced Pluripotent Stem Cells (iPSCs) Market: By Application

  1. Introduction   
    1. Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026 (USD Million)       
  2. Drug Development    
    1. Drug Development: Induced Pluripotent Stem Cells (iPSCs) Market, 2020-2026 (USD Million)
  3. Regenerative Medicine          
    1. Regenerative Medicine: Induced Pluripotent Stem Cells (iPSCs) Market, 2020-2026 (USD Million)
  4. Academic Research   
    1. Academic Research: Induced Pluripotent Stem Cells (iPSCs) Market, 2020-2026 (USD Million)
  5. Others
    1. Others: Induced Pluripotent Stem Cells (iPSCs) Market, 2020-2026 (USD Million)

Induced Pluripotent Stem Cells (iPSCs) Market: By Region

  1. Introduction   
    1. Global Induced Pluripotent Stem Cells (iPSCs) Market, Regional Analysis, 2020-2026(USD Million)   
  2. North America
    1. North America Induced Pluripotent Stem Cells (iPSCs) Market, Regional Analysis, 2020-2026(USD Million)    
      1. By Derived Cell Type    
        1. North America Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)        
      2. By End Users   
        1. North America Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)     
      3. By Application 
        1. North America Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)        
      4. By Country      
        1. U.S      
          1. By Derived Cell Type    
            1. U.S. Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)   
          2. By End Users   
            1. U.S. Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)
          3. By Application 
            1. U.S. Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)
        2. Canada.          
          1. By Derived Cell Type    
            1. Canada Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)      
          2. By End Users   
            1. Canada Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)   
          3. By Application 
            1. Canada Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)   
        3. Mexico
          1. By Derived Cell Type    
            1. Mexico Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)      
          2. By End Users   
            1. Mexico Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)
          3. By Application 
            1. Mexico Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)   
  3. Europe           
    1. Europe Induced Pluripotent Stem Cells (iPSCs) Market, Regional Analysis, 2020-2026(USD Million)   
      1. By Derived Cell Type    
        1. Europe Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)     
      2. By End Users   
        1. Europe Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)     
      3. By Application 
        1. Europe Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)     
      4. By Country      
        1. Germany         
          1. By Derived Cell Type    
            1. Germany Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)      
          2. By End Users   
            1. Germany Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)   
          3. By Application 
            1. Germany Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)   
        2. UK       
          1. By Derived Cell Type    
            1. UK Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)   
          2. By End Users   
            1. UK Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)
          3. By Application 
            1. UK Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)
        3. France
          1. By Derived Cell Type    
            1. France Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)      
          2. By End Users   
            1. France Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)
          3. By Application 
            1. France Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)   
        4. Italy     
          1. By Derived Cell Type    
            1. Italy Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)   
          2. By End Users   
            1. Italy Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)
          3. By Application 
            1. Italy Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)
  4. Asia Pacific    
    1. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market, Regional Analysis, 2020-2026(USD Million)    
      1. By Derived Cell Type    
        1. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)        
      2. By End Users   
        1. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)                 
      3. By Application 
        1. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)     
      4. By Country      
        1. China  
          1. By Derived Cell Type    
            1. China Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)   
          2. By End Users   
            1. China Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)
          3. By Application 
            1. China Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)
        2. Japan  
          1. By Derived Cell Type    
            1. Japan Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)   
          2. By End Users   
            1. Japan Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)
          3. By Application 
            1. Japan Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)
        3. India   
          1. By Derived Cell Type    
            1. India Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)   
          2. By End Users   
            1. India Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)
          3. By Application 
            1. India Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)
        4. South Korea   
          1. By Derived Cell Type    
            1. South Korea Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)      
          2. By End Users   
            1. South Korea Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)   
          3. By Application 
            1. South Korea Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)
        5. Rest Of Apac   
          1. By Derived Cell Type    
            1. Rest Of Apac, Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)
          2. By End Users   
            1. Rest Of Apac Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)   
          3. By Application 
            1. Rest Of Apac Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)   
  5. Central & South America       
    1. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market, Regional Analysis, 2020-2026(USD Million)          
      1. By Derived Cell Type    
        1. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)    
      2. By End Users   
        1. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)                     
      3. By Application 
        1. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million) 
      4. By Country      
        1. Brazil   
          1. By Derived Cell Type    
            1. Brazil Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)   
          2. By End Users   
            1. Brazil Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)
          3. By Application 
            1. Brazil Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)
    2. Middle East & Africa  
      1. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market, Regional Analysis, 2020-2026(USD Million)          
        1. By Derived Cell Type    
          1. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)          
        2. By End Users   
          1. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)        
        3. By Application 
          1. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)        
        4. By Country      
          1. Saudi Arabia   
            1. By Derived Cell Type    
              1. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)
            2. By End Users   
              1. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)   
            3. By Application 
              1. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)   
          2. UAE     
            1. By Derived Cell Type    
              1. UAE Induced Pluripotent Stem Cells (iPSCs) Market, By Derived Cell Type, 2020-2026(USD Million)   
            2. By End Users   
              1. UAE Induced Pluripotent Stem Cells (iPSCs) Market, By End Users, 2020-2026(USD Million)
            3. By Application 
              1. UAE Induced Pluripotent Stem Cells (iPSCs) Market, By Application, 2020-2026(USD Million)

The global Induced Pluripotent Stem Cells (iPSCs) Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

Induced Pluripotent Stem Cells (iPSCs) Market

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Induced Pluripotent Stem Cells (iPSCs) Market.

Induced Pluripotent Stem Cells (iPSCs) Market

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Induced Pluripotent Stem Cells (iPSCs) Market

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.

Induced Pluripotent Stem Cells (iPSCs) Market

To request a free sample copy of this report, please complete the form below

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy
Request A Free Sample Report
Request For Customization

 

What questions do you have? Get quick response from our industry experts. Request a Free Consultation